China could ‘corner’ biopharmaceutical sector with new plan, US panel warns
BioPharma DiveJonathan GardnerNovember 19, 2026
A commission called on U.S. lawmakers to act quickly to prevent an overdependence on China that could leave American patients vulnerable to supply chain weaponization.
